Protara Therapeutics, Inc. (TARA) Retained Earnings (Accumulated Deficit) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Protara Therapeutics, Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2013 to 2024.
  • Protara Therapeutics, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$211 M, a 25.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$211 M -$42.5 M -25.1% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$200 M -$40.4 M -25.3% Dec 31, 2023 10-Q 2024-05-02
Q3 2023 -$190 M -$69.2 M -57.2% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 -$180 M -$67 M -59.1% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$169 M -$64.2 M -61.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$160 M -$66 M -70.2% Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$121 M -$37.2 M -44.4% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$113 M -$40.3 M -55.2% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 -$105 M -$44.5 M -74% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 -$94 M -$47.3 M -101% Dec 31, 2021 10-K 2023-03-08
Q3 2021 -$83.8 M -$45.8 M -121% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$73 M -$43 M -144% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$60.2 M -$37.4 M -164% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$46.8 M -$34 M -266% Dec 31, 2020 10-K 2022-03-09
Q3 2020 -$38 M +$186 M +83% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 -$30 M +$192 M +86.5% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 -$22.8 M +$194 M +89.5% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 -$12.8 M +$198 M +93.9% Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$224 M -$18.6 M -9.08% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 -$222 M -$21.6 M -10.8% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$217 M -$21.2 M -10.8% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 -$210 M -$20.7 M -10.9% Dec 31, 2018 10-K 2020-03-20
Q3 2018 -$205 M -$21 M -11.4% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$201 M -$28.8 M -16.8% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 -$196 M -$29.5 M -17.8% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 -$190 M -$30 M -18.8% Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$184 M -$31.4 M -20.5% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 -$172 M -$26.2 M -18% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 -$166 M -$28.5 M -20.7% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 -$160 M -$28.5 M -21.7% Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$153 M -$27.9 M -22.3% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 -$146 M -$26.2 M -21.9% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 -$138 M -$23.3 M -20.4% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 -$131 M -$21.4 M -19.5% Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$125 M -$8.37 M -7.18% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 -$120 M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 -$114 M Mar 31, 2015 10-Q 2015-05-13
Q4 2014 -$110 M -$9.36 M -9.31% Dec 31, 2014 10-K 2016-03-14
Q3 2014 -$117 M Sep 30, 2014 10-Q 2014-11-25
Q4 2013 -$101 M Dec 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.